bacucco
Nuovo forumer
Ciao legoper chi era dentro
NBRV + 40%
![]()
Sinovant Sciences and Nabriva Therapeutics Announce Positive Topline Results from Phase 3 Trial of Lefamulin in Chinese Adults with Community Acquired Bacterial Pneumonia (CABP)
Lefamulin was shown to be non-inferior to moxifloxacin, with 76.8% of lefamulin-treated patients meeting the efficacy endpoint of Investigator Assessment of Clinical Response (IACR) at Test of Cure (TOC), compared to 71.4% of patients treated with moxifloxacinLefamulin was generally safe and...finance.yahoo.com
Come leggi il comportamento di nbrv oggi?
X conto mio hanno approfittato del rialzo x liquidare le posizioni